Display options
Cite
Codd AS, Al-Taei S, Tabi Z. Cross-talk between cancer-initiating cells and immune cells: considerations for combination therapies. Ann Transl Med. 2016;4:S56doi: 10.21037/atm.2016.10.30.
Codd, A. S., Al-Taei, S., & Tabi, Z. (2016). Cross-talk between cancer-initiating cells and immune cells: considerations for combination therapies. Annals of translational medicine, 4S56. https://doi.org/10.21037/atm.2016.10.30
Codd, Amy S, et al. "Cross-talk between cancer-initiating cells and immune cells: considerations for combination therapies." Annals of translational medicine vol. 4 (2016): S56. doi: https://doi.org/10.21037/atm.2016.10.30
Codd AS, Al-Taei S, Tabi Z. Cross-talk between cancer-initiating cells and immune cells: considerations for combination therapies. Ann Transl Med. 2016 Oct;4:S56. doi: 10.21037/atm.2016.10.30. PMID: 27868024; PMCID: PMC5104641.
Copy Download .nbib Format: NLM
Share it on

Ann Transl Med. 2016 Oct;4:S56. doi: 10.21037/atm.2016.10.30.

Cross-talk between cancer-initiating cells and immune cells: considerations for combination therapies.

Annals of translational medicine

Amy S Codd, Saly Al-Taei, Zsuzsanna Tabi

Affiliations

  1. Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, CF14 2TL, UK.

PMID: 27868024 PMCID: PMC5104641 DOI: 10.21037/atm.2016.10.30

[No abstract available.]

Conflict of interest statement

The authors have no conflicts of interest to declare.

References

  1. Oncoimmunology. 2014 Dec 13;3(9):e955331 - PubMed
  2. Clin Cancer Res. 2011 Oct 1;17(19):6174-84 - PubMed
  3. J Cancer Res Clin Oncol. 2013 Jan;139(1):159-70 - PubMed
  4. Cancer Sci. 2014 Apr;105(4):389-95 - PubMed
  5. Eur J Cancer. 2013 Jan;49(1):272-80 - PubMed
  6. PLoS One. 2015 Oct 07;10(10):e0139867 - PubMed
  7. Nature. 2010 Jul 1;466(7302):133-7 - PubMed
  8. Cancer Res. 2010 Dec 1;70(23):9969-78 - PubMed
  9. Eur J Cancer. 2014 Feb;50(3):649-55 - PubMed
  10. Clin Cancer Res. 2016 Jul 15;22(14):3571-81 - PubMed
  11. Oncotarget. 2016 Mar 8;7(10):11223-37 - PubMed
  12. Tissue Antigens. 2013 Jun;81(6):428-34 - PubMed
  13. Mol Cancer Ther. 2015 Mar;14(3):828-34 - PubMed
  14. Expert Opin Biol Ther. 2015 Jun;15(6):787-801 - PubMed
  15. Stem Cells. 2015 Jul;33(7):2085-92 - PubMed
  16. Mediators Inflamm. 2016;2016:9012369 - PubMed
  17. Head Neck. 2011 Feb;33(2):208-15 - PubMed
  18. J Immunol. 2006 Mar 15;176(6):3402-9 - PubMed
  19. Nat Rev Cancer. 2008 Oct;8(10):755-68 - PubMed
  20. Neuro Oncol. 2016 Feb;18(2):153-9 - PubMed

Publication Types